SEARCH

SEARCH BY CITATION

REFERENCE

  • 1
    Rustin GJ, van der Burg ME. A randomized trial in ovarian cancer (OC) of early treatment of relapse based on CA125 level alone versus delayed treatment based on conventional clinical indicators (MRC OV05/EORTC 55955 trials) [abstract]. J Clin Oncol. 2009; 27( 18 suppl). Abstract 1.
  • 2
    Society of Gynecologic Oncologists. Statement on Use of CA125 for Monitoring Ovarian Cancer. Available at: http://www.sgo.org/WorkArea/showcontent.aspx?id=2702.